Guo Q, Lu Y, Liu W, Lan G, Lan T. The global, regional, and national disease burden of breast cancer attributable to tobacco from 1990 to 2019: a global burden of disease study. BMC Public Health. 2024;24(1):107.

Article  PubMed  PubMed Central  Google Scholar 

Waks AG, Winer EP. Breast Cancer Treatment: a review. JAMA. 2019;321(3):288–300.

Article  CAS  PubMed  Google Scholar 

Franzoi MA, Agostinetto E, Perachino M, Del Mastro L, de Azambuja E, Vaz-Luis I, et al. Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. Lancet Oncol. 2021;22(7):e303–13.

Article  CAS  PubMed  Google Scholar 

Ferreira AR, Di Meglio A, Pistilli B, Gbenou AS, El-Mouhebb M, Dauchy S, et al. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. Ann Oncol. 2019;30(11):1784–95.

Article  CAS  PubMed  Google Scholar 

Aggarwal S, Verma SS, Aggarwal S, Gupta SC. Drug repurposing for breast cancer therapy: old weapon for new battle. Semin Cancer Biol. 2021;68:8–20.

Article  CAS  PubMed  Google Scholar 

Lord SR, Harris AL. Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? Br J Cancer. 2023;128(6):958–66.

Article  PubMed  PubMed Central  Google Scholar 

De A, Kuppusamy G. Metformin in breast cancer: preclinical and clinical evidence. Curr Probl Cancer. 2020;44(1):100488.

Article  PubMed  Google Scholar 

Schlander M, Hernandez-Villafuerte K, Cheng CY, Mestre-Ferrandiz J, Baumann M. How much does it cost to Research and develop a New Drug? A systematic review and Assessment. PharmacoEconomics. 2021;39(11):1243–69.

Article  PubMed  PubMed Central  Google Scholar 

Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostatistics. 2019;20(2):273–86.

Article  PubMed  Google Scholar 

Dowden H, Munro J. Trends in clinical success rates and therapeutic focus. Nat Rev Drug Discov. 2019;18(7):495–6.

Article  CAS  PubMed  Google Scholar 

Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856–60.

Article  CAS  PubMed  Google Scholar 

King EA, Davis JW, Degner JF. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. Marchini J, editor. PLoS Genet. 2019;15(12):e1008489.

Minikel EV, Painter JL, Dong CC, Nelson MR. Refining the impact of genetic evidence on clinical success. Nature [Internet]. 2024 Apr 17 [cited 2024 Apr 28]; https://www.nature.com/articles/s41586-024-07316-0

Collaborators NBCS, Investigators ABCTB, Investigators CFAOCS, Michailidou K, Lindström S, Dennis J, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551(7678):92–4.

Article  Google Scholar 

Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet. 2021;22(10):658–71.

Article  CAS  PubMed  Google Scholar 

Tam V, Patel N, Turcotte M, Bossé Y, Paré G, Meyre D. Benefits and limitations of genome-wide association studies. Nat Rev Genet. 2019;20(8):467–84.

Article  CAS  PubMed  Google Scholar 

Schaid DJ, Chen W, Larson NB. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat Rev Genet. 2018;19(8):491–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nam Y, Jung SH, Yun JS, Sriram V, Singhal P, Byrska-Bishop M, et al. Discovering comorbid diseases using an inter-disease interactivity network based on biobank-scale PheWAS data. Bioinformatics. 2023;39(1):btac822.

Article  CAS  PubMed  Google Scholar 

Melamed RD, Emmett KJ, Madubata C, Rzhetsky A, Rabadan R. Genetic similarity between cancers and comorbid mendelian diseases identifies candidate driver genes. Nat Commun. 2015;6(1):7033.

Article  CAS  PubMed  Google Scholar 

Lalagkas PN, Melamed RD. Shared etiology of mendelian and complex disease supports drug discovery. BMC Med Genomics. 2024;17(1):228.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020;52(6):572–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Howard DM, Adams MJ, Clarke TK, Hafferty JD, Gibson J, Shirali M, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci. 2019;22(3):343–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Graham SE, Clarke SL, Wu KHH, Kanoni S, Zajac GJM, Ramdas S, et al. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600(7890):675–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

The Profile Study, Australian Prostate Cancer BioResource (APCB), Study TIMPACT, Canary PASS, Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3. The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet., ), 2018;50(7):928–36.

Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604(7906):502–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50(11):1505–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo H, Li JJ, Lu Q, Hou L. Detecting local genetic correlations with scan statistics. Nat Commun. 2021;12(1):2033.

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: Generalized Gene-Set Analysis of GWAS Data. Tang H, editor. PLoS Comput Biol. 2015;11(4):e1004219.

Barbeira AN, Pividori M, Zheng J, Wheeler HE, Nicolae DL, Im HK. Integrating predicted transcriptome from multiple tissues improves association detection. Plagnol V, editor. PLoS Genet. 2019;15(1):e1007889.

Zhu GL, Xu C, Yang K, bin, Tang SQ, Tang LL, Chen L, et al. Causal relationship between genetically predicted depression and cancer risk: a two-sample bi-directional mendelian randomization. BMC Cancer. 2022;22(1):353.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson KE, Siewert KM, Klarin D, Damrauer SM, the VA Million Veteran Program, Chang KM et al. The relationship between circulating lipids and breast cancer risk: A Mendelian randomization study. Minelli C, editor. PLoS Med. 2020;17(9):e1003302.

Ren ZJ, Cao DH, Zhang Q, Ren PW, Liu LR, Wei Q, et al. First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis. BMC Cancer. 2019;19(1):871.

Article  PubMed  PubMed Central  Google Scholar 

Cui Y, Lu W, Shao T, Zhuo Z, Wang Y, Zhang W. Severe mental illness and the risk of breast cancer: A two-sample, two-step multivariable Mendelian randomization study. Montazeri A, editor. PLoS ONE. 2023;18(9):e0291006.

Pearson-Stuttard J, Papadimitriou N, Markozannes G, Cividini S, Kakourou A, Gill D, et al. Type 2 diabetes and Cancer: an Umbrella Review of Observational and mendelian randomization studies. Cancer Epidemiol Biomarkers Prev. 2021;30(6):1218–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watanabe K, Taskesen E, Van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8(1):1826.

Article  PubMed  PubMed Central  Google Scholar 

Ghoussaini M, Nelson MR, Dunham I. Future prospects for human genetics and genomics in drug discovery. Curr Opin Struct Biol. 2023;80:102568.